Indraprastha Medical Corporation Limited held a Board of Directors meeting on 29th October 2026 from 3:00 PM to 4:15 PM. The Board considered and approved the Un-audited Financial Results for the quarter and half-year ended 30th September 2026, along with the Limited Review Report of the statutory auditor.

Financial Performance Highlights

Quarter Ended 30 September 2026 (Q2 FY27):

  • Revenue from operations: ₹412.85 crore (compared to ₹406.15 crore in Q1 FY27 and ₹381.03 crore in Q2 FY26)
  • Other income: ₹8.55 crore
  • Total income: ₹421.40 crore
  • Total expenses: ₹349.33 crore
  • Profit before tax: ₹72.07 crore
  • Tax expense: ₹18.49 crore (₹16.85 crore current tax + ₹1.64 crore deferred tax)
  • Profit after tax: ₹53.58 crore
  • Other comprehensive income: -₹0.96 crore (net of tax)
  • Total comprehensive income: ₹52.62 crore
  • Earnings per share (Basic and Diluted): ₹5.84

Half-Year Ended 30 September 2026 (H1 FY27):

  • Revenue from operations: ₹819.00 crore (compared to ₹746.09 crore in H1 FY26)
  • Other income: ₹16.97 crore
  • Total income: ₹835.97 crore
  • Total expenses: ₹689.08 crore
  • Profit before tax: ₹146.89 crore
  • Tax expense: ₹37.46 crore (₹36.53 crore current tax + ₹0.93 crore deferred tax)
  • Profit after tax: ₹109.43 crore
  • Other comprehensive income: ₹1.29 crore (net of tax)
  • Total comprehensive income: ₹110.72 crore
  • Earnings per share (Basic and Diluted): ₹11.94

Expense Breakdown (Quarter Ended 30 September 2026)

  • Cost of materials consumed: ₹67.42 crore
  • Employee benefits expense: ₹78.53 crore
  • Professional charges to doctors: ₹111.53 crore
  • Finance costs: ₹1.66 crore
  • Depreciation and amortization: ₹12.26 crore
  • Other expenses: ₹77.93 crore

Balance Sheet Position (as at 30 September 2026)

  • Total assets: ₹1,118.44 crore (compared to ₹991.36 crore as at 31 March 2026)
  • Non-current assets: ₹605.05 crore
  • Current assets: ₹513.39 crore
  • Equity: ₹814.43 crore (₹91.67 crore share capital + ₹722.76 crore other equity)
  • Non-current liabilities: ₹80.75 crore
  • Current liabilities: ₹223.26 crore

Cash Flow Statement (H1 FY27)

  • Cash generated from operations: ₹137.18 crore
  • Net cash from operating activities: ₹109.35 crore
  • Net cash used in investing activities: -₹101.38 crore
  • Net cash used in financing activities: -₹6.42 crore
  • Net increase in cash and cash equivalents: ₹1.55 crore
  • Closing cash and cash equivalents: ₹6.48 crore

Segment Information

  • The Company operates in a single segment: Healthcare
  • No additional segment disclosures required under Ind AS 108
  • No subsidiaries, associates, or joint ventures as of 30 September 2026

Capital Structure

  • Paid-up equity share capital: ₹91.67 crore (face value ₹10 per share)
  • Reserves (excluding revaluation reserves): ₹648.70 crore as shown in previous audited balance sheet